Tislelizumab

Indian pharmaceutical company headquartered in Mumbai, Maharashtra, founded in 1977 by Gracias Saldanha and listed on the National Stock Exchange and BSE. Develops, manufactures and markets generic and branded generic medicines and active pharmaceutical ingredients with a focus on dermatology, respiratory and oncology, selling in India, the United States, Europe, Latin America and emerging markets, and runs innovative research through its subsidiary Glenmark Specialty and the biologics business Ichnos Glenmark Innovation.